María Elena González-González

Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence.

Mariana Segovia‐Mendoza, María Elena González-González, David Barrera et al. · PubMed · 2015 · 134 citations · Full text

Tumor Biology, Breast Oncology, Endocrine-related Cancer +15

Biological Effects of Recombinant Human Zona Pellucida Proteins on Sperm Function1

Pedro Caballero-Campo, Mayel Chirinos, Xue Jun Fan et al. · Biology of Reproduction · 2006 · 64 citations · Full text

Spermatogenesis, Fertility, Genetics +19

Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells

Mariana Segovia‐Mendoza, María Elena González-González, Isela Martínez-Reza et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2014 · 60 citations

Tumor Biology, Breast Oncology, Antiproliferative Activity +12

Recombinant human ZP3-induced sperm acrosome reaction: Evidence for the involvement of T- and L-type voltage-gated calcium channels

José Omar, Óscar Hernández‐Hernández, Mayel Chirinos et al. · Biochemical and Biophysical Research Communications · 2010 · 33 citations

Spermatogenesis, Infertility, Andrology +11

Human sperm degradation of zona pellucida proteins contributes to fertilization

Analilia Saldívar-Hernández, María Elena González-González, Ana A. Sánchez-Tusié et al. · Reproductive Biology and Endocrinology · 2015 · 24 citations · Full text